Indications And Dose
Adjuvant treatment of oestrogen-receptor-positive early breast cancer in postmenopausal women following 2–3 years of tamoxifen therapy | Advanced breast cancer in postmenopausal women in whom anti-oestrogen therapy has failed ▶BY MOUTH ▶Adult: 25 mg daily
PDF page 1028

